Global Atherosclerosis Pipeline Report 2016 - Review of 40 Companies & Drug Profiles - Research and Markets

Research and Markets has announced the addition of the "Atherosclerosis - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Atherosclerosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Atherosclerosis and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

1. Introduction
2. Atherosclerosis Overview
3. Therapeutics Development
4. Pipeline Products for Atherosclerosis - Overview
5. Pipeline Products for Atherosclerosis - Comparative Analysis
6. Atherosclerosis - Therapeutics under Development by Companies
7. Atherosclerosis - Therapeutics under Investigation by Universities/Institutes
8. Atherosclerosis Products Glance
9. Late Stage Products
10. Clinical Stage Products
11. Early Stage Products
12. Atherosclerosis - Products under Development by Companies
13. Atherosclerosis - Products under Investigation by Universities/Institutes
14. Atherosclerosis - Companies Involved in Therapeutics Development

• Ache Laboratorios Farmaceuticos S/A
• advanceCor GmbH
• AFFiRiS AG
• Amgen Inc.
• Arisaph Pharmaceuticals, Inc.
• Artery Therapeutics, Inc.
• AstraZeneca Plc
• Athera Biotechnologies AB
• AtheroNova Inc.
• Bayer AG
• Campus Technologies Freiburg GmbH
• Cardax Pharmaceuticals, Inc.
• Cerenis Therapeutics Holding SA
• ChemoCentryx, Inc.
• CohBar, Inc.
• Daewoong Pharmaceutical Co., Ltd.
• Daiichi Sankyo Company, Limited
• DoNatur GmbH
• Dybly AG
• Exicure, Inc.
• GenKyoTex S.A.
• Jenrin Discovery, Inc.
• Johnson & Johnson
• KineMed, Inc.
• Kowa Company, Ltd.
• La Jolla Pharmaceutical Company
• Lead Discovery Center GmbH
• Merck & Co., Inc.
• The Medicines Company
• Therapix Biosciences Ltd
• Tolerys SA
• Vascular Biogenics Ltd.
• Vericel Corporation
• Vitae Pharmaceuticals, Inc.
• XBiotech USA, Inc.
  

For more information visit http://www.researchandmarkets.com/research/vsk9nh/atherosclerosis

View source version on businesswire.com: http://www.businesswire.com/news/home/20160610005413/en/